Piramal acquires Minrad InternationalIllustrative image – not actual.

Piramal Healthcare has acquired Minrad International, New York, a provider of generic inhalation anesthetics for $40 million ( approx Rs.195 crore). The two firms have signed a definitive merger agreement for Piramal to acquire Minrad. The Minrad has two plants which sells three products - isoflourane,enflurane and sevoflurane - in this segment.

As per the agreement, the stockholders of Minrad will receive $0.12 a share in cash and Piramal will also acquire Minrad's 8 per cent senior secured convertible notes from the note holders.

Post merger, Minrad will become a newly incorporated wholly-owned subsidiary of Piramal. The deal is likely to be complete by March 2009.

In connection with the agreement, Piramal has also agreed to acquire Minrad's 8 per cent senior secured convertible notes from the note holders. The acquisition is expected to close by February-March 2009.

← All latest storiesBack to top →